Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: Contract/Agreement, Product/Service, Funding, Business Update

Elicit Plant Validates on a Large Scale the Performance of its BEST-a Product for Corn That Reduces Crops' Water Consumption and Addresses the Challenges of Climate Change


Elicit Plant, an agricultural biotechnology company specialized in crops' resistance to water stress based on a phytosterol-based technology platform, announced today that it has validated the performance on a large scale of its solution dedicated to the sustainable transition of agriculture along with increased return on investment for farmers. The 150 open-field trials carried out in 2022 on a global scale (Europe, North America, South America) by independent cooperators have shown a consistent and high performance of its solution to reduce the impact of water shortage on corn crops: +12% productivity gains (+10 bushels per acre on average/+0,6T/Ha).

This performance, unique in this product category, is based on revolutionary scientific and agronomic work carried out by Elicit Plant. The agtech company has developed a plant growth regulation technology based on phytosterols, molecules found in plants, that enable crops to better resist water stress by naturally stimulating their inherent and specific metabolic responses.

"Those remarkable open-field trial results, conducted on three continents with different climatic characteristics, confirm Elicit Plant's scientific excellence and its ability to develop unique products that address the challenges of climate change in agriculture. They also comfort our ambitious international development strategy," says Jean-François Déchant, President and co-founder of Elicit Plant. Elicit Plant's products have been tested in the field since 2019 with a total of 500 trials to date with a win rate (positive yield response) close to 90%. Over these years, the company has systematically determined the best application timing, proprietary formulation and weather and soil conditions to drive the best results in consistency and yield increases.

Elicit Plant's ability to raise an additional 10 million euros over the past six months via highly competitive national and European R&D programs (e.g. funding under the Governmental Plan "France 2030" -the SADEA grant to accelerate farmers' sustainability transition-, European Innovation Council's acceleration program) and the positive results of its large-scale trials, conclude a year marked by successful milestones:

- A Series A financing round of ?16 million in February 2022, led by Sofinnova Partners with the support of the ECBF fund, the French Tech Seed Fund managed by Bpifrance and historical investors.
- The successful launch of its BEST-a product line for corn crops in France, listed by more than 50 cooperatives, including the largest ones in the country. Market approvals for its product line dedicated to corn crops in Ukraine and Brazil.
- The tripling of the workforce to sustain the firm's global growth. Elicit Plant now employs more than sixty people ranging from R&D, to regulatory, marketing and sales.
- Breakthrough scientific discoveries rewarded by the most selective innovation competitions: DeepTech BPI, FrenchTech Agri20, EIC Accelerator, SADEA-France 2030.

Determined to give its full power to its breakthrough proprietary technological platform, Elicit Plant has drawn up an ambitious roadmap, that includes the strengthening of its governance, the diversification of its product pipeline over the next 3 to 5 years and the development of its partnership and scientific strategy in North America.

About Elicit Plant
Elicit Plant is an agbiotech company created in 2017 with the ambition to become a sustainability transition champion in agriculture and respond to the global challenges of water stress in crops. Based in Charente (France), the firm has 60 employees across its R&D Center established within a 1,000 ha farm, its offices in Lyon, and its subsidiary in Brazil. Elicit Plant's proprietary technology is delivered through foliar application of phytosterols, molecules found in plants that reduce crops' water consumption. Open-field trials have shown an average yield increase of +10 bushels per acre on average. In 2022, Elicit Plant began marketing its BEST-a product line for corn crops in France, and obtained market approvals for Ukraine and Brazil. For more information: www.elicit-plant.com


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: